Q96L73 (NSD1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific EC=2.1.1.43 Alternative name(s): Androgen receptor coactivator 267 kDa protein Androgen receptor-associated protein of 267 kDa H3-K36-HMTase H4-K20-HMTase Lysine N-methyltransferase 3B Nuclear receptor-binding SET domain-containing protein 1 Short name=NR-binding SET domain-containing protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 2696 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Histone methyltransferase. Preferentially methylates 'Lys-36' of histone H3 and 'Lys-20' of histone H4 (in vitro). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. Ref.11 |
| Catalytic activity | S-adenosyl-L-methionine + L-lysine-[histone] = S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone]. Ref.11 |
| Subunit structure | Interacts with the ligand-binding domains of RARA and THRA in the absence of ligand; in the presence of ligand the interaction is severely disrupted but some binding still occurs. Interacts with the ligand-binding domains of RXRA and ESRRA only in the presence of ligand. Interacts with ZNF496 By similarity. Interacts with AR DNA- and ligand-binding domains. Ref.1 |
| Subcellular location | Nucleus. Chromosome Probable. |
| Tissue specificity | Expressed in the fetal/adult brain, kidney, skeletal muscle, spleen, and the thymus, and faintly in the lung. |
| Involvement in disease | Defects in NSD1 are the cause of Sotos syndrome (SOTOSS) [MIM:117550]; also known as cerebral gigantism. It is a disorder characterized by excessively rapid growth, acromegalic features, and a nonprogressive cerebral disorder with mental retardation. High-arched palate and prominent jaw are noted in several patients. Most cases of Sotos syndrome are sporadic and may represent new dominant mutation. Ref.4 Ref.5 Ref.11 Ref.12 Ref.13 Defects in NSD1 are the cause of Weaver syndrome (WES) [MIM:277590]. WES is a syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Ref.12 Ref.13 Defects in NSD1 are a cause of Beckwith-Wiedemann syndrome (BWS) [MIM:130650]. BWS is a genetically heterogeneous disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. Ref.5 Note=A chromosomal aberration involving NSD1 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NUP98. Note=A chromosomal aberration involving NSD1 is found in an adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into NSD1 generates a NUP98-NSD1 fusion product. |
| Sequence similarities | Belongs to the histone-lysine methyltransferase family. Contains 1 AWS domain. Contains 4 PHD-type zinc fingers. Contains 1 post-SET domain. Contains 2 PWWP domains. Contains 1 SET domain. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96L73-1) Also known as: ARA267-beta; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96L73-2) Also known as: ARA267-alpha; The sequence of this isoform differs from the canonical sequence as follows: 1-269: Missing. 270-279: QLNSINLSFQ → MPLKTRTALS | ||||||
| Isoform 3 (identifier: Q96L73-3) The sequence of this isoform differs from the canonical sequence as follows: 310-412: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 2696 | 2696 | Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific | PRO_0000186070 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Domain | 323 – 388 | 66 | PWWP 1 | ||||||||||||||||||||||||||||||||
| Domain | 1756 – 1818 | 63 | PWWP 2 | ||||||||||||||||||||||||||||||||
| Domain | 1890 – 1940 | 51 | AWS | ||||||||||||||||||||||||||||||||
| Domain | 1941 – 2063 | 123 | SET | ||||||||||||||||||||||||||||||||
| Domain | 2066 – 2082 | 17 | Post-SET | ||||||||||||||||||||||||||||||||
| Zinc finger | 1543 – 1589 | 47 | PHD-type 1 | ||||||||||||||||||||||||||||||||
| Zinc finger | 1590 – 1646 | 57 | PHD-type 2 | ||||||||||||||||||||||||||||||||
| Zinc finger | 1707 – 1751 | 45 | PHD-type 3 | ||||||||||||||||||||||||||||||||
| Zinc finger | 2118 – 2165 | 48 | PHD-type 4; atypical | ||||||||||||||||||||||||||||||||
| Region | 1952 – 1954 | 3 | S-adenosyl-L-methionine binding | ||||||||||||||||||||||||||||||||
| Region | 1994 – 1997 | 4 | S-adenosyl-L-methionine binding | ||||||||||||||||||||||||||||||||
| Region | 2020 – 2021 | 2 | S-adenosyl-L-methionine binding | ||||||||||||||||||||||||||||||||
| Region | 2060 – 2066 | 7 | Inhibits enzyme activity in the absence of bound histone | ||||||||||||||||||||||||||||||||
| Compositional bias | 2207 – 2421 | 215 | Pro-rich | ||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||
| Binding site | 2065 | 1 | S-adenosyl-L-methionine | ||||||||||||||||||||||||||||||||
| Binding site | 2071 | 1 | S-adenosyl-L-methionine | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Modified residue | 209 | 1 | Phosphoserine Ref.10 | ||||||||||||||||||||||||||||||||
| Modified residue | 483 | 1 | Phosphoserine Ref.9 | ||||||||||||||||||||||||||||||||
| Modified residue | 486 | 1 | Phosphoserine Ref.9 | ||||||||||||||||||||||||||||||||
| Modified residue | 766 | 1 | Phosphoserine Ref.7 | ||||||||||||||||||||||||||||||||
| Modified residue | 2471 | 1 | Phosphoserine Ref.8 | ||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 269 | 269 | Missing in isoform 2. | VSP_007682 | |||||||||||||||||||||||||||||||
| Alternative sequence | 270 – 279 | 10 | QLNSINLSFQ → MPLKTRTALS in isoform 2. | VSP_007683 | |||||||||||||||||||||||||||||||
| Alternative sequence | 310 – 412 | 103 | Missing in isoform 3. | VSP_007684 | |||||||||||||||||||||||||||||||
| Natural variant | 614 | 1 | V → L. Ref.12 Corresponds to variant rs3733875 [ dbSNP | Ensembl ]. | VAR_015775 | |||||||||||||||||||||||||||||||
| Natural variant | 691 | 1 | A → T. Ref.12 Corresponds to variant rs28932177 [ dbSNP | Ensembl ]. | VAR_015776 | |||||||||||||||||||||||||||||||
| Natural variant | 726 | 1 | S → P. Ref.12 Ref.14 Corresponds to variant rs28932178 [ dbSNP | Ensembl ]. | VAR_015777 | |||||||||||||||||||||||||||||||
| Natural variant | 1036 | 1 | A → P. Ref.12 Corresponds to variant rs28932179 [ dbSNP | Ensembl ]. | VAR_015778 | |||||||||||||||||||||||||||||||
| Natural variant | 1091 | 1 | L → I. Ref.12 Corresponds to variant rs35597015 [ dbSNP | Ensembl ]. | VAR_015779 | |||||||||||||||||||||||||||||||
| Natural variant | 1616 | 1 | H → L in SOTOSS. Ref.12 | VAR_015780 | |||||||||||||||||||||||||||||||
| Natural variant | 1637 | 1 | L → P in SOTOSS. Ref.12 | VAR_015781 | |||||||||||||||||||||||||||||||
| Natural variant | 1674 | 1 | C → W in SOTOSS. Ref.12 | VAR_015782 | |||||||||||||||||||||||||||||||
| Natural variant | 1687 | 1 | I → N in SOTOSS. Ref.13 | VAR_015783 | |||||||||||||||||||||||||||||||
| Natural variant | 1792 | 1 | G → V in SOTOSS. Ref.12 | VAR_015784 | |||||||||||||||||||||||||||||||
| Natural variant | 1925 | 1 | C → R in SOTOSS. Ref.12 | VAR_015785 | |||||||||||||||||||||||||||||||
| Natural variant | 1955 | 1 | G → D in SOTOSS. Ref.13 | VAR_015786 | |||||||||||||||||||||||||||||||
| Natural variant | 1984 | 1 | R → Q in SOTOSS; loss of enzyme activity. Ref.11 Ref.13 | VAR_015787 | |||||||||||||||||||||||||||||||
| Natural variant | 1997 | 1 | Y → C in WES. Ref.13 | VAR_015788 | |||||||||||||||||||||||||||||||
| Natural variant | 2005 | 1 | R → Q in SOTOSS; strongly reduced enzyme activity. Ref.11 Ref.12 | VAR_015789 | |||||||||||||||||||||||||||||||
| Natural variant | 2017 | 1 | R → Q in SOTOSS; loss of enzyme activity. Ref.11 Ref.12 | VAR_015790 | |||||||||||||||||||||||||||||||
| Natural variant | 2017 | 1 | R → W in SOTOSS. Ref.13 | VAR_015791 | |||||||||||||||||||||||||||||||
| Natural variant | 2143 | 1 | H → Q in WES. Ref.12 | VAR_015792 | |||||||||||||||||||||||||||||||
| Natural variant | 2183 | 1 | C → S in WES. Ref.12 | VAR_015793 | |||||||||||||||||||||||||||||||
| Natural variant | 2250 | 1 | M → I. Ref.12 Corresponds to variant rs35848863 [ dbSNP | Ensembl ]. | VAR_015794 | |||||||||||||||||||||||||||||||
| Natural variant | 2261 | 1 | M → T. Ref.12 Corresponds to variant rs34165241 [ dbSNP | Ensembl ]. | VAR_015795 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 1914 | 1 | R → C: Reduced enzyme activity. Ref.11 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 1952 | 1 | R → W: Nearly abolished enzyme activity. Ref.11 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1306 | 1 | H → D in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1397 | 1 | P → Q in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1478 | 1 | A → V in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1959 – 1960 | 2 | KT → QE in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1963 | 1 | K → R in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1982 | 1 | R → M in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1986 – 1991 | 6 | RYAQEH → KHAHEN in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 1995 | 1 | N → H in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2001 | 1 | L → I in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2016 | 1 | A → S in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2022 | 1 | C → S in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2030 | 1 | Q → L in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2033 | 1 | S → T in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2045 – 2046 | 2 | LS → VC in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2049 | 1 | K → P in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2061 | 1 | E → D in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2066 | 1 | G → E in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2071 | 1 | K → R in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2075 | 1 | P → S in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2304 – 2305 | 2 | TK → AQ in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2352 | 1 | R → S in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2539 | 1 | L → S in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2543 | 1 | P → S in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2567 – 2591 | 25 | PGPLS…QQLPA → QGFFTKSPALVENKGKTKWV GRPTNYLH in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2597 | 1 | G → W in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 2608 – 2612 | 5 | ASLPT → PSSPN in AAK92049. Ref.3 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Helix | 1852 – 1863 | 12 | |||||||||||||||||||||||||||||||||
| Helix | 1889 – 1891 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 1901 – 1903 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 1912 – 1915 | 4 | |||||||||||||||||||||||||||||||||
| Turn | 1922 – 1924 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 1935 – 1938 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 1957 – 1960 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 1978 – 1990 | 13 | |||||||||||||||||||||||||||||||||
| Beta strand | 1998 – 2002 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 2005 – 2008 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 2015 – 2018 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 2026 – 2028 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 2043 – 2046 | 4 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells." Wang X., Yeh S., Wu G., Hsu C.-L., Wang L., Chang T., Yang Y., Guo Y., Chang C. J. Biol. Chem. 276:40417-40423(2001) [PubMed: 11509567] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), INTERACTION WITH AR. |
| [2] | "Molecular characterization of NSD1, a human homologue of the mouse Nsd1 gene." Kurotaki N., Harada N., Yoshiura K., Sugano S., Niikawa N., Matsumoto N. Gene 279:197-204(2001) [PubMed: 11733144] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [3] | "A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia." Jaju R.J., Fidler C., Haas O.A., Strickson A.J., Watkins F., Clark K., Cross N.C., Cheng J.F., Aplan P.D., Kearney L., Boultwood J., Wainscoat J.S. Blood 98:1264-1267(2001) [PubMed: 11493482] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), CHROMOSOMAL TRANSLOCATION WITH NUP98. |
| [4] | "Haploinsufficiency of NSD1 causes Sotos syndrome." Kurotaki N., Imaizumi K., Harada N., Masuno M., Kondoh T., Nagai T., Ohashi H., Naritomi K., Tsukahara M., Makita Y., Sugimoto T., Sonoda T., Hasegawa T., Chinen Y., Tomita Ha H.A., Kinoshita A., Mizuguchi T., Yoshiura Ki K. Matsumoto N.Nat. Genet. 30:365-366(2002) [PubMed: 11896389] [Abstract] Cited for: INVOLVEMENT IN SOTOSS. |
| [5] | "Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome." Baujat G., Rio M., Rossignol S., Sanlaville D., Lyonnet S., Le Merrer M., Munnich A., Gicquel C., Cormier-Daire V., Colleaux L. Am. J. Hum. Genet. 74:715-720(2004) [PubMed: 14997421] [Abstract] Cited for: INVOLVEMENT IN SOTOSS AND BWS. |
| [6] | "Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts." La Starza R., Gorello P., Rosati R., Riezzo A., Veronese A., Ferrazzi E., Martelli M.F., Negrini M., Mecucci C. Genes Chromosomes Cancer 41:395-399(2004) [PubMed: 15382262] [Abstract] Cited for: INVOLVEMENT IN MYELODYSPLASTIC SYNDROME. |
| [7] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-766, MASS SPECTROMETRY. Tissue: Prostate cancer. |
| [8] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2471, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-486, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [10] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209, MASS SPECTROMETRY. |
| [11] | "The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation." Qiao Q., Li Y., Chen Z., Wang M., Reinberg D., Xu R.M. J. Biol. Chem. 286:8361-8368(2011) [PubMed: 21196496] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1852-2082 IN COMPLEX WITH S-ADENOSYL-L-METHIONINE AND ZINC IONS, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF ARG-1914 AND ARG-1952, CHARACTERIZATION OF SOTOSS VARIANTS GLN-1984; GLN-2005 AND GLN-2017. |
| [12] | "NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes." Douglas J., Hanks S., Temple I.K., Davies S., Murray A., Upadhyaya M., Tomkins S., Hughes H.E., Cole T.R.P., Rahman N. Am. J. Hum. Genet. 72:132-143(2003) [PubMed: 12464997] [Abstract] Cited for: VARIANTS SOTOSS LEU-1616; PRO-1637; TRP-1674; VAL-1792; ARG-1925; GLN-2005 AND GLN-2017, VARIANTS WES GLN-2143 AND SER-2183, VARIANTS LEU-614; THR-691; PRO-726; PRO-1036; ILE-1091; ILE-2250 AND THR-2261. |
| [13] | "Spectrum of NSD1 mutations in Sotos and Weaver syndromes." Rio M., Clech L., Amiel J., Faivre L., Lyonnet S., Le Merrer M., Odent S., Lacombe D., Edery P., Brauner R., Raoul O., Gosset P., Prieur M., Vekemans M., Munnich A., Colleaux L., Cormier-Daire V. J. Med. Genet. 40:436-440(2003) [PubMed: 12807965] [Abstract] Cited for: VARIANTS SOTOSS ASN-1687; ASP-1955; GLN-1984 AND TRP-2017, VARIANT WES CYS-1997. |
| [14] | "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome." Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K., Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L., Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A., Abbott S. Wilson R.K.Nature 456:66-72(2008) [PubMed: 18987736] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] PRO-726. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF380302 mRNA. Translation: AAL27991.1. AY049721 mRNA. Translation: AAL06645.1. AF395588 mRNA. Translation: AAL40694.1. AF322907 mRNA. Translation: AAK92049.1. | ||||||||||||
| IPI | IPI00102107. IPI00173901. IPI00332367. | ||||||||||||
| RefSeq | NP_071900.2. NM_022455.4. NP_758859.1. NM_172349.2. | ||||||||||||
| UniGene | Hs.106861. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q96L73. | ||||||||||||
| SMR | Q96L73. Positions 316-388, 1541-1589, 1602-1850, 1852-2082, 2117-2203. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-58517N. | ||||||||||||
| IntAct | Q96L73. 3 interactions. | ||||||||||||
| STRING | Q96L73. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q96L73. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 32469769. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q96L73. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000355783; ENSP00000348031; ENSG00000165671. ENST00000439151; ENSP00000395929; ENSG00000165671. | ||||||||||||
| GeneID | 64324. | ||||||||||||
| KEGG | hsa:64324. | ||||||||||||
| UCSC | uc003mfr.2. human. uc003mft.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 64324. | ||||||||||||
| GeneCards | GC05P176560. | ||||||||||||
| HGNC | HGNC:14234. NSD1. | ||||||||||||
| MIM | 117550. phenotype. 130650. phenotype. 277590. phenotype. 606681. gene. | ||||||||||||
| neXtProt | NX_Q96L73. | ||||||||||||
| Orphanet | 228415. 5q35 microduplication syndrome. 238613. Beckwith-Wiedemann syndrome due to NSD1 mutation. 821. Sotos syndrome. 3447. Weaver syndrome. | ||||||||||||
| PharmGKB | PA31790. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | HBG278040. | ||||||||||||
| HOVERGEN | HBG007518. | ||||||||||||
| InParanoid | Q96L73. | ||||||||||||
| OMA | NIDKMRH. | ||||||||||||
| OrthoDB | EOG49GKFN. | ||||||||||||
| PhylomeDB | Q96L73. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q96L73. | ||||||||||||
| Bgee | Q96L73. | ||||||||||||
| CleanEx | HS_NSD1. | ||||||||||||
| Genevestigator | Q96L73. | ||||||||||||
| GermOnline | ENSG00000165671. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR006560. AWS. IPR003616. Post-SET_dom. IPR000313. PWWP. IPR001214. SET_dom. IPR019786. Zinc_finger_PHD-type_CS. IPR011011. Znf_FYVE_PHD. IPR001965. Znf_PHD. IPR019787. Znf_PHD-finger. IPR001841. Znf_RING. IPR013083. Znf_RING/FYVE/PHD. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:3.30.40.10. Znf_RING/FYVE/PHD. 3 hits. | ||||||||||||
| KO | K15588. | ||||||||||||
| Pfam | PF00628. PHD. 1 hit. PF00855. PWWP. 2 hits. PF00856. SET. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00570. AWS. 1 hit. SM00249. PHD. 5 hits. SM00508. PostSET. 1 hit. SM00293. PWWP. 2 hits. SM00184. RING. 1 hit. SM00317. SET. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF57903. FYVE_PHD_ZnF. 3 hits. | ||||||||||||
| PROSITE | PS51215. AWS. 1 hit. PS50868. POST_SET. 1 hit. PS50812. PWWP. 2 hits. PS50280. SET. 1 hit. PS01359. ZF_PHD_1. 2 hits. PS50016. ZF_PHD_2. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 66241. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | NSD1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96L73 Secondary accession number(s): Q96PD8, Q96RN7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with